Mauro Di Vito Nolfi

L'aquila, 67100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

NF-κB Involvement in Glaucoma-Associated Neuroinflammation: Focus on Glial Cells.

NF-κB Involvement in Glaucoma-Associated Neuroinflammation: Focus on Glial Cells.

Journal: Frontiers in bioscience (Landmark edition)

Published: August 09, 2025

A 3D Bioprinting Approach to Studying Retinal Müller Cells.

A 3D Bioprinting Approach to Studying Retinal Müller Cells.

Journal: Genes

Published: October 03, 2024

Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis.

Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis.

Journal: Cancers

Published: August 11, 2024

Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression.

Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression.

Journal: Genes

Published: September 25, 2023

MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression.

MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression.

Journal: International journal of molecular sciences

Published: March 31, 2023

Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures.

Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures.

Journal: Pharmaceutics

Published: December 15, 2022

The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target.

The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target.

Journal: Biomedicines

Published: July 31, 2022

NF-κB: A Druggable Target in Acute Myeloid Leukemia.

NF-κB: A Druggable Target in Acute Myeloid Leukemia.

Journal: Cancers

Published: July 06, 2022

Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer.

Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer.

Journal: Cells

Published: June 03, 2022

Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma.

Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: May 09, 2022

EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?

EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?

Journal: Frontiers in oncology

Published: May 01, 2022

Ultrasound-Based Method for the Identification of Novel MicroRNA Biomarkers in Prostate Cancer.

Ultrasound-Based Method for the Identification of Novel MicroRNA Biomarkers in Prostate Cancer.

Journal: Genes

Published: October 01, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026